| Literature DB >> 26064947 |
Yu-Ling Zuo1, Di-Ping Gong2, Bi-Ze Li3, Juan Zhao4, Ling-Yue Zhou4, Fang-Yang Shao2, Zhao Jin5, Yuan He2.
Abstract
Oral lichen planus (OLP) is a chronic inflammatory disease that affects oral mucosa, some of which may finally develop into oral squamous cell carcinoma. Therefore, pinpointing the molecular mechanisms underlying the pathogenesis of OLP is important to develop efficient treatments for OLP. Recently, the accumulation of the large amount of omics data, especially transcriptome data, provides opportunities to investigate OLPs from a systematic perspective. In this paper, assuming that the OLP associated genes have functional relationships, we present a new approach to identify OLP related gene modules from gene regulatory networks. In particular, we find that the gene modules regulated by both transcription factors (TFs) and microRNAs (miRNAs) play important roles in the pathogenesis of OLP and many genes in the modules have been reported to be related to OLP in the literature.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26064947 PMCID: PMC4433662 DOI: 10.1155/2015/731264
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Schematic illustration of the pipeline to detect the TF-miRNA coregulation networks in oral lichen planus.
Figure 2The TF-miRNA coregulation network with 6 modules, where the green nodes represent differentially expressed miRNAs, red nodes denote the transcription factors, and gray nodes represent genes in modules, respectively.
The detailed information about the 6 network modules as well as their TF and miRNA regulators.
| Module | #Nodes | #Edges | miRNAs | Transcription factors |
|
| ||||
| Module 1 | 134 | 952 | hsa-miR-628-5p | SALL2, PEG3, ZNF865, HES3, ZNF283, ZIM2, FOSB, PAX6, SIX2, ZNF616, KDM5D, SRY, RFX4, and ZFY |
| Module 2 | 62 | 594 | hsa-miR-595 | ASCL4 |
| Module 3 | 160 | 1301 | hsa-miR-34c-5p | ELK3, RFX8, MIXL1, HIF1A, and ZNF552 |
| Module 4 | 80 | 405 | hsa-miR-29a | LIN28A |
| Module 5 | 55 | 335 | hsa-miR-190 | THRA, NR1D1, and NR1D2 |
| Module 6 | 43 | 241 | hsa-miR-146b-5p | ZNF626 |
Examples of genes from each network module that have been reported to be related to OLP or oral cancer.
| Network module | Gene symbol | PubMed IDs |
|
| ||
| Module 1 | KRT18 | 19575986; 22677743; 7527618; |
| SHH | 11857543; 21945071; 21496886 | |
| FOSB | 19653276; 15926923 | |
|
| ||
| Module 2 | MAGEA3 | 19187853; 12855658 |
| KRT1 | 20002980; 16334838; 10896780 | |
| MAGEA6 | 18197853; | |
|
| ||
| Module 3 | HIF1A | 19717330; 19449077; 18630523 |
| PTEN | 17067457; 15453811; 15805158 | |
| IGF1R | 17786320; 23106397; 19584075 | |
|
| ||
| Module 4 | CP | 23812204; 19884712; 17066447 |
| ABCG2 | 18429968; 15801936; 15618737 | |
| ALDH1A1 | 22725270; 22782852; 21441790 | |
|
| ||
| Module 5 | IDH1 | 22385606; 21383741; 19378339 |
| CRABP2 | 19197536; 16568407; 11437413 | |
|
| ||
| Module 6 | CD55 | 21545652; 17234541; 15668483 |
| FGFR4 | 18487077; 20127014; 23481570 | |
| CYP3A5 | 16338276; 18628519; 1808564 | |
Functional enrichment analysis of genes in network modules.
| Network module | Enriched functions related to OLP |
|
|---|---|---|
| Module 1 | GO:0030901~midbrain development | 0.00337086 |
| GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 0.00560592 | |
| GO:0008285~negative regulation of cell proliferation | 0.01400315 | |
| GO:0007600~sensory perception | 0.032006 | |
| GO:0007435~salivary gland morphogenesis | 0.0376765 | |
| GO:0002052~positive regulation of neuroblast proliferation | 0.04294326 | |
|
| ||
| Module 2 | GO:0004623~phospholipase A2 activity | 0.00233 |
| GO:0050877~neurological system process | 0.00764739 | |
| GO:0051606~detection of stimulus | 0.04745557 | |
|
| ||
| Module 3 | GO:0001525~angiogenesis | 0.00589117 |
| GO:0005829~cytosol | 0.00679876 | |
| GO:0042060~wound healing | 0.01651834 | |
| GO:0045740~positive regulation of DNA replication | 0.01978034 | |
| GO:0007173~epidermal growth factor receptor signaling pathway | 0.01978034 | |
| GO:0015629~actin cytoskeleton | 0.04636455 | |
|
| ||
| Module 4 | GO:0006879~cellular iron ion homeostasis | 0.00604241 |
| GO:0000041~transition metal ion transport | 0.029349054 | |
| GO:0055114~oxidation reduction | 0.03217 | |
| hsa00980:Metabolism of xenobiotics by cytochrome P450 | 0.03978611 | |
|
| ||
| Module 5 | GO:0003707~steroid hormone receptor activity | 0.00495459 |
| GO:0006766~vitamin metabolic process | 0.01044366 | |
| GO:0001523~retinoid metabolic process | 0.04657368 | |
| GO:0006776~vitamin A metabolic process | 0.04657368 | |
|
| ||
| Module 6 | GO:0008395~steroid hydroxylase activity | 0.02851299 |
| GO:0005887~integral to plasma membrane | 0.02900047 | |
| GO:0008202~steroid metabolic process | 0.04570667 | |
Figure 3The regulatory relationship between miRNA and their targets in our regulatory network.